SCHEMBL1890179

SCHEMBL1890179

Nc1ncnc2c1ncn2[C@H]1CC(O)[C@@H](CN(C(=O)[C@@H](N)Cc2ccc(O)cc2)P(=O)(O)O)O1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.51
ENPP1 P22413 3/20 0.49
P2RY1 P47900 2/20 0.49
DOT1L Q8TEK3 1/20 0.43
DNMT1 P26358 3/20 0.43
DNMT3B Q9UBC3 1/20 0.43
ATM Q13315 1/20 0.41
TRDMT1 O14717 2/20 0.41
TRPM2 O94759 2/20 0.41
DNPH1 O43598 1/20 0.41
PRKAB2 O43741 1/20 0.41
LDHA P00338 1/20 0.41
ADRB2 P07550 1/20 0.41
FBP1 P09467 1/20 0.41
SRC P12931 1/20 0.41
ADORA1 P30542 1/20 0.41
P2RY2 P41231 1/20 0.41
PRKAG1 P54619 1/20 0.41
PRKAA2 P54646 1/20 0.41
PDE4D Q08499 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1894562 0.88 POLB (0.56) POLBENPP1P2RY1DNMT1DNMT3B
SCHEMBL1890560 0.87 POLB (0.55) POLBENPP1P2RY1DOT1LDNMT1
SCHEMBL1894460 0.86 POLB (0.57) POLBENPP1P2RY1DOT1LDNMT1
SCHEMBL1893414 0.85 QARS1 (0.54) POLBENPP1P2RY1DOT1LDNMT1
SCHEMBL1890394 0.84 HARS1 (0.52) POLBENPP1P2RY1DNMT1DNMT3B
SCHEMBL1890171 0.81 POLB (0.59) POLBENPP1P2RY1DOT1LATM
SCHEMBL1895195 0.76 POLB (0.53) POLBENPP1P2RY1DNMT1DNMT3B
SCHEMBL1885190 0.75 POLB (0.60) POLBENPP1P2RY1TRPM2DNPH1
Phosphoric Acid SCHEMBL1969280 0.74 POLB (0.68) POLBENPP1P2RY1TRPM2DNPH1
Deoxyadenosine SCHEMBL1969830 0.74 POLB (0.68) POLBENPP1P2RY1DOT1LDNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242087-B2 Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents K.U.LEUVEN RESEARCH & DEVELOPMENT (BE) 2012-08-14 US disclosed
US-20110112046-A9 PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2011-05-12 US disclosed
US-20100093656-A1 PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2010-04-15 US disclosed
EP-2144921-A2 PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS K.U. Leuven Research and Development (BE) 2010-01-20 EP disclosed
WO-2008104408-A2 PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS K. U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2008-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112046-A9 PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS MTAP, POLRMT, PNP POLB 12/4885ENPP1 17/4885P2RY1 575/4885
US-20100093656-A1 PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS MTAP, POLRMT, PNP POLB 12/4885ENPP1 17/4885P2RY1 575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.